{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:57:59Z","timestamp":1757627879424,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MAPRONANO ACE","award":["MAPRONANO ACE"],"award-info":[{"award-number":["MAPRONANO ACE"]}]},{"DOI":"10.13039\/100004441","name":"Swedish International Development Cooperation Agency","doi-asserted-by":"crossref","award":["51180060"],"award-info":[{"award-number":["51180060"]}],"id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Sickle cell disease (SCD) is characterised by chronic oxidative stress. However, there is limited information on how polymorphisms in cytokine genes influence oxidative stress in SCD patients. The study aimed to determine the effect of Interleukin gene (<jats:italic>IL-10<\/jats:italic>) and Tumor Necrosis Factor (<jats:italic>TNF<\/jats:italic>\n              <jats:sub>\n                <jats:italic>\u03b1\u03b2<\/jats:italic>\n              <\/jats:sub>) polymorphisms on oxidative stress and cytokine levels in SCD patients from Mulago hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A case control study with cross-sectional sample size of 163 SCD patients and 189 healthy controls was carried out. The extent of oxidative stress was quantified using Malondialdehyde (MDA) by spectrophotometry. Levels of IL-10 and TNF-\u03b1 were measured using the Enzyme-Linked Immuno-Sorbent Assay (ELISA). The Amplification Refractory Mutation System polymerase chain reaction (ARMS-PCR) assay was used to genotype IL10-1082\u00a0A\u2009&gt;\u2009G, (rs1800896), IL10-819\u00a0C\u2009&gt;\u2009T (rs1800871) and TNF-\u03b1-308G\u2009&gt;\u2009A (rs1800629) and TNF-\u03b2\u2009+\u2009252\u00a0A\u2009&gt;\u2009G (rs909253) gene polymorphisms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Samples showed significantly (<jats:italic>P<\/jats:italic>\u2009=\u20090.0063) higher median plasma levels of MDA in SCD patients (2.756\u00b5M) than healthy controls (2.364\u00b5M). A similar trend was observed with significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) higher median plasma levels of IL-10 in SCD patients (20.37pg\/ml) than healthy controls (7.5pg\/ml). The most frequent genotype for IL-10 (-1082, rs1800896) gene polymorphism was heterozygous GA (62.6%). No significant association between IL10 (-1082G\u2009&gt;\u2009A, rs1800896) gene polymorphisms and SCD was observed (OR\u2009=\u20091.08, 95% CI\u2009=\u20090.54\u20132.14, <jats:italic>P<\/jats:italic>\u2009=\u20090.87). Yet, IL10 homozygous GG (-1082, rs1800896) (22.12pg\/ml) that was found to be significantly associated (<jats:italic>P<\/jats:italic>\u2009=\u20090.0234) with increased plasma levels of IL-10 as compared to heterozygous genotype (GA) (13.94pg\/ml) in SCD patients. Similarly, higher levels of MDA were found to be significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) associated with homozygous GG at IL-10 (-1082, rs1800896). The most frequent and only reported genotype for TNF-\u03b1\/\u03b2 gene polymorphisms were heterozygous GA, thus no associations were described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In conclusion, our results suggest that the IL10 (-1082 G\u2009&gt;\u2009A, rs1800896) gene polymorphism is associated with increased oxidative stress and IL-10 cytokine level in Ugandan SCD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40659-025-00639-w","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:35:38Z","timestamp":1756874138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL10 (-1082 G&gt;A, rs1800896) gene polymorphisms are associated with oxidative stress in sickle cell disease patients in Uganda"],"prefix":"10.1186","volume":"58","author":[{"given":"Cissy B.","family":"Namuleme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M.","family":"Kasozi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"639_CR1","doi-asserted-by":"publisher","unstructured":"Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: A neglected cause of early childhood mortality. Am J Prev Med. 2011;41:S398\u2013405. Available from: https:\/\/doi.org\/10.1016\/j.amepre.2011.09.013","DOI":"10.1016\/j.amepre.2011.09.013"},{"key":"639_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/journal.pntd.0002120","volume":"7","author":"RE Ware","year":"2013","unstructured":"Ware RE. Is sickle cell anemia a neglected tropical disease?? PLoS Negl Trop Dis. 2013;7:5\u20138.","journal-title":"PLoS Negl Trop Dis"},{"key":"639_CR3","doi-asserted-by":"crossref","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10.","DOI":"10.1371\/journal.pmed.1001484"},{"key":"639_CR4","doi-asserted-by":"publisher","unstructured":"Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I et al. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): A cross-sectional study. Lancet Glob Heal. 2016;4:e195\u2013200. Available from: https:\/\/doi.org\/10.1016\/S2214-109X(15)00288-0","DOI":"10.1016\/S2214-109X(15)00288-0"},{"key":"639_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1203\/pdr.0b013e31802d7754","volume":"61","author":"SA Akohoue","year":"2007","unstructured":"Akohoue SA, Shankar S, Milne GL, Morrow J, Chen KY, Ajayi WU, et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007;61:233\u20138.","journal-title":"Pediatr Res"},{"key":"639_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4084\/mjhid.2018.017","volume":"10","author":"AE Alagbe","year":"2018","unstructured":"Alagbe AE, Olaniyi JA, Aworanti OW. Adult sickle cell anaemia patients in bone pain crisis have elevated pro-inflammatory cytokines. Mediterr J Hematol Infect Dis. 2018;10:1\u20139.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"639_CR7","first-page":"263","volume":"68","author":"JD Nicola Conran, Belcher","year":"2018","unstructured":"Nicola Conran, Belcher JD. Inflammation in sickle cell disease Nicola. Physiol Behav. 2018;68:263\u201399.","journal-title":"Physiol Behav"},{"key":"639_CR8","first-page":"1","volume":"7","author":"C Antwi-Boasiako","year":"2019","unstructured":"Antwi-Boasiako C, Dankwah GB, Aryee R, Hayfron-Benjamin C, Donkor ES, Campbell AD. Oxidative profile of patients with sickle cell disease. Med Sci (Basel Switzerland). 2019;7:1\u20138.","journal-title":"Med Sci (Basel Switzerland)"},{"key":"639_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1128\/CVI.00286-15","volume":"22","author":"S Sarray","year":"2015","unstructured":"Sarray S, Almawi WY. Contribution of reduced interleukin-10 levels to the pathogenesis of osteomyelitis in children with sickle cell disease. Clin Vaccine Immunol. 2015;22:1020\u20134.","journal-title":"Clin Vaccine Immunol"},{"key":"639_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00439-008-0578-5","volume":"124","author":"C Ouma","year":"2008","unstructured":"Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, et al. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet. 2008;124:515\u201324.","journal-title":"Hum Genet"},{"key":"639_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/GEI.S2626","volume":"2","author":"A Driss","year":"2009","unstructured":"Driss A, Asare KO, Hibbert JM, Gee BE, Adamkiewicz TV, Stiles JK. Sickle cell disease in the post genomic era: A Monogenic disease with a polygenic phenotype. Genomics Insights. 2009;2:23\u201348.","journal-title":"Genomics Insights"},{"key":"639_CR12","doi-asserted-by":"crossref","unstructured":"Waterfall CM, Cobb BD. Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis. Nucleic Acids Res. 2020;29.","DOI":"10.1093\/nar\/29.23.e119"},{"key":"639_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4221-y","volume":"19","author":"SM Atiku","year":"2019","unstructured":"Atiku SM, Louise N, Kasozi DM. Severe oxidative stress in sickle cell disease patients with uncomplicated plasmodium falciparum malaria in kampala, Uganda. BMC Infect Dis. 2019;19:1\u201310.","journal-title":"BMC Infect Dis"},{"key":"639_CR14","first-page":"4175","volume":"PID","author":"V Iranpur-Mobarakeh","year":"2010","unstructured":"Iranpur-Mobarakeh V, Esmailizadeh A. Rapid-extraction-of-high-quality-DNA-from-whole-blood-storedat-4-C-for-long-period. Protoc Online. 2010;PID:4175.","journal-title":"Protoc Online"},{"key":"639_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0966-3274(99)80030-6","volume":"7","author":"C Perrey","year":"1999","unstructured":"Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-\u03b1, TNF-\u03b2 and TGF-\u03b21 gene polymorphisms [2]. Transpl Immunol. 1999;7:127\u20138.","journal-title":"Transpl Immunol"},{"key":"639_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1179\/102453308X343356","volume":"13","author":"MAF Chaves","year":"2008","unstructured":"Chaves MAF, Leonart MSS, do Nascimento AJ. Oxidative process in erythrocytes of individuals with hemoglobin S. Hematology. 2008;13:187\u201392.","journal-title":"Hematology"},{"key":"639_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1684\/ecn.2013.0328","volume":"24","author":"B Keikhaei","year":"2013","unstructured":"Keikhaei B, Mohseni AR, Norouzirad R, Alinejadi M, Ghanbari S, Shiravi F, et al. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. Eur Cytokine Netw. 2013;24:45\u201352.","journal-title":"Eur Cytokine Netw"},{"key":"639_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/CVI.00145-09","volume":"17","author":"BOP Musa","year":"2010","unstructured":"Musa BOP, Onyemelukwe GC, Hambolu JO, Mamman AI, Isa AH. Pattern of serum cytokine expression and T-Cell subsets in sickle cell disease patients in vaso-occlusive crisis. Clin Vaccine Immunol. 2010;17:602\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"639_CR19","doi-asserted-by":"publisher","unstructured":"Belis\u00e1rio AR, Sales RR, Toledo NE, Velloso-Rodrigues C, Silva CM, Viana MB. Interleukin-10 haplotypes are not associated with acute cerebral ischemia or high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia. Rev Bras Hematol Hemoter. 2017;39:108\u201314. Available from: https:\/\/doi.org\/10.1016\/j.bjhh.2016.09.017","DOI":"10.1016\/j.bjhh.2016.09.017"},{"key":"639_CR20","doi-asserted-by":"crossref","unstructured":"Tozatto-Maio K, Girot R, Ly ID, Silva Pinto AC, Rocha V, Fernandes F et al. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Front Immunol. 2020;11.","DOI":"10.3389\/fimmu.2020.02041"},{"key":"639_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12291-012-0231-x","volume":"27","author":"S Bhagat","year":"2012","unstructured":"Bhagat S, Patra PK, Thakur AS. Association of inflammatory biomarker C-reactive protein, lipid peroxidation and antioxidant capacity marker with HbF level in sickle cell disease patients from Chattisgarh. Indian J Clin Biochem. 2012;27:394\u20139.","journal-title":"Indian J Clin Biochem"},{"key":"639_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2141.2006.06277.x","volume":"135","author":"PB Walter","year":"2006","unstructured":"Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, et al. Oxidative stress and inflammation in iron-overloaded patients with \u03b2-thalassaemia or sickle cell disease. Br J Haematol. 2006;135:254\u201363.","journal-title":"Br J Haematol"},{"key":"639_CR23","doi-asserted-by":"publisher","unstructured":"Sarray S, Saleh LR, Lisa Saldanha F, Al-Habboubi HH, Mahdi N, Almawi WY. Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine. 2015;72:43\u20137. Available from: https:\/\/doi.org\/10.1016\/j.cyto.2014.11.030","DOI":"10.1016\/j.cyto.2014.11.030"},{"key":"639_CR24","doi-asserted-by":"crossref","unstructured":"Mahavar N, Naseri M, Sarab GA, Fereidouni M, Ziaee M, Safari H et al. IL-10-1082 A\/G (RS1800896) polymorphism is effective in clearing hepatitis B virus infection. Jundishapur J Microbiol. 2021;14.","DOI":"10.5812\/jjm.93003"},{"key":"639_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ajh.22012","volume":"86","author":"E Nur","year":"2011","unstructured":"Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJB. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86:484\u20139.","journal-title":"Am J Hematol"},{"key":"639_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hemonc.2015.11.002","volume":"9","author":"JEA Cavalcante","year":"2016","unstructured":"Cavalcante JEA, MacHado RPG, Laurentino MR, De Jesus Dos Santos TE, Bandeira ICJ, Filho PAM, et al. Clinical events and their relation to the tumor necrosis factor-alpha and interleukin-10 genotypes in Sickle-Cell-Anemia patients. Hematol Oncol Stem Cell Ther. 2016;9:14\u20139.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"639_CR27","doi-asserted-by":"publisher","unstructured":"Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. Brand Liem J Hematol Oncol. 2022;15:20. Available from: https:\/\/doi.org\/10.1186\/s13045-022-01237-z","DOI":"10.1186\/s13045-022-01237-z"},{"key":"639_CR28","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.34117\/bjdv9n2-030","volume":"9","author":"M Luciano","year":"2023","unstructured":"Luciano M, de Albuquerque MP, De Moura Neto CCMX. Interleukin-6 gene polymorphisms influencing in hematological indices from sickle cell anemia patients. Brazilian J Dev. 2023;9:6581\u201394.","journal-title":"Brazilian J Dev"},{"key":"639_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.exphem.2016.03.008","volume":"44","author":"SC Olenscki Gilli","year":"2016","unstructured":"Olenscki Gilli SC, Pericole FV, Benites BD, Sippert E\u00c2, Castilho LM, Addas-Carvalho M, et al. Cytokine polymorphisms in sickle cell disease and the relationship with cytokine expression. Exp Hematol. 2016;44:583\u20139.","journal-title":"Exp Hematol"},{"key":"639_CR30","unstructured":"Cavallone L, Lio D, Scola L, Crivello A, Candore G, Bonafe M et al. Promoter Polymorph Longev. 2002;30\u20133."},{"key":"639_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"24","author":"DM Turner","year":"1997","unstructured":"Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1\u20138.","journal-title":"Eur J Immunogenet"},{"key":"639_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/sj.gene.6364227","volume":"6","author":"JN Wilson","year":"2005","unstructured":"Wilson JN, Rockett K, Jallow M, Pinder M, Sisay-Joof F, Newport M, et al. Analysis of IL10 haplotypic associations with severe malaria. Genes Immun. 2005;6:462\u20136.","journal-title":"Genes Immun"},{"key":"639_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox11050967","volume":"11","author":"R Bou-Fakhredin","year":"2022","unstructured":"Bou-Fakhredin R, De Franceschi L, Motta I, Eid AA, Taher AT, Cappellini MD. Redox balance in \u03b2-Thalassemia and sickle cell disease: A love and hate relationship. Antioxidants. 2022;11:1\u201317.","journal-title":"Antioxidants"},{"key":"639_CR34","doi-asserted-by":"crossref","unstructured":"Aboderin FI, Oduola T, Davison GM, Oguntibeju OO. A review of the relationship between the immune response, inflammation, oxidative stress, and the pathogenesis of sickle cell anaemia. Biomedicines. 2023;11.","DOI":"10.20944\/preprints202307.1039.v1"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00639-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-025-00639-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00639-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:24:28Z","timestamp":1757481868000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-025-00639-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1186\/s40659-025-00639-w","relation":{},"ISSN":["0717-6287"],"issn-type":[{"type":"electronic","value":"0717-6287"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Makerere University School of Health Sciences Research and Ethics Committee (MAKSHSREC-2021-90). A waiver of informed consent to use both the SCD blood samples from mother study, and healthy control blood samples from Blood bank, Nakasero was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the manuscript for Publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}